Phenotypic clustering analysis of patients rejected for mitral valve interventions: implications for future transcatheter technologies.
Sebastian Ludwig, Augustin Coisne, Kenza Hamzi...
https://pubmed.ncbi.nlm.nih.gov/40329826/Actively Recruiting
Led by Universitätsklinikum Hamburg-Eppendorf · Updated on 2026-05-07
1000
Participants Needed
43
Research Sites
4 weeks
Total Duration
Researchers are studying clinical outcomes in patients undergoing transcatheter mitral valve replacement TMVR for mitral insufficiency. This multinational registry focuses on patients treated with TMVR in real-world practice and collects data on those who have undergone screening for TMVR. Some historical data include patients who received other treatments like edge-to-edge repair, mitral valve surgery, or medical therapy. The registry includes patients who successfully underwent TMVR with any device. Patients who failed TMVR screening and underwent other treatments such as mitral valve edge-to-edge repair, mitral valve surgery, or medical therapy were previously included but are no longer systematically enrolled. The study collects data over various timepoints to observe the effects of these therapies. Participants are followed for at least 30 days after treatment with echocardiography and clinical evaluations. Researchers measure mitral insufficiency severity, device-related complications within 30 days, and longer-term outcomes like mortality, rehospitalization for heart failure, and unplanned mitral valve interventions over 12 months. This observational registry aims to understand outcomes and safety in patients treated with TMVR and related therapies in routine care.
CONDITIONS
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
S
Sebastian Ludwig, MD
L
Lena Strotmann, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Universitätsklinikum Hamburg-Eppendorf
Lead Sponsor
Montreal Heart Institute
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At least 30 days up to 12 months
Participants who undergo routine care for mitral insufficiency, including transcatheter mitral valve replacement, edge-to-edge repair, surgery, or medical therapy, are observed for outcomes.
Follow-up visits at baseline and after treatment up to 12 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Sebastian Ludwig, Augustin Coisne, Kenza Hamzi...
https://pubmed.ncbi.nlm.nih.gov/40329826/Lena Strotmann, Andrea Scotti, Augustin Coisne...
https://pubmed.ncbi.nlm.nih.gov/42575577/Augustin Coisne, Sebastian Ludwig, Andrea Scotti...
https://pubmed.ncbi.nlm.nih.gov/39243262/Sebastian Ludwig, Lenard Conradi, David J Cohen...
https://pubmed.ncbi.nlm.nih.gov/37194288/Universitätsklinikum Hamburg-Eppendorf
Lead Sponsor
Montreal Heart Institute
Collaborating Sponsor